PRA Health Sciences posted a solid set of financials for the fourth quarter as it predicts double-digit growth in the coming year.

Covance has helped buoy LabCorp earnings in the fourth quarter as its leadership team hails a "transformative year."

AMRI is hailing a "transformative year" as it posts a set of strong financials for the past 12 months.

Catalent Pharma Solutions remained stagnant in its fiscal second quarter, as global currency fluctuations undid baseline growth in its banner businesses.…

Parexel lowered its fiscal year revenue projections by about 2% despite posting modest growth in the last quarter, working through a sizable restructuring…

German contract researcher Evotec grew its revenue by 50% in the first 9 months of 2015, executing its hybrid model and expanding its list of Big Pharma…

Catalent ticked up its year-over-year revenue in the company's fiscal first quarter, absorbing a significant hit from foreign exchange fluctuations and…

PRA Health Sciences posted another quarter of revenue growth but is narrowing its full-year sales projection.